In Other News

• Tiny Mineral Particles a Better Vehicle for Delivering mRNA COVID-19 Vaccine

• Regeneron Launches Phase 3 Trial of Double Antibody Cocktail for Treatment and Prevention of COVID-19

• BD Launches Portable, Rapid POC Antigen Test to Detect SARS-CoV-2 in 15 Minutes

• Far-UVC Light Kills 99.9% of Airborne Coronaviruses Within 25 Minutes in New Study

• Scientists Identify Molecules with Unique Features that Shut Down SARS-Cov-2 Polymerase Reaction

• Moderna's Phase III COVID-19 Vaccine Trial Delayed

• COVID-19-Influenza Combination Test Granted FDA Emergency Use Authorization

• Transasia Launches COVID-19 IgG Antibody Kits with 98% Accuracy and at 20% Cost of RT-PCR Tests

• Erba Mannheim Makes SARS-CoV-2 Testing Available to Labs Everywhere

• Fluxergy Collaborates with Mass General Brigham to Evaluate One-Hour COVID-19 Diagnostic Test

• COVID-19 Infection Significantly Associated with Strokes, Find Researchers

• Tesla Building Portable, Automated “RNA Microfactories” for CureVac's COVID-19 Vaccine

• New Study Confirms COVID-19 Vaccine Will Need to Elicit T Cells to Work alongside Antibodies

• Fujifilm’s AI Platform, REiLI Chosen by ASST Vimercate Hospital to Support Operators in Fight Against COVID-19

• Eurofins Launches CE-IVD Marked Rapid POC Testing Devices to Identify Past Exposure to COVID-19 in 10 Minutes

• Pfizer and BioNTech Announce Early Positive Data from Phase 1/2 Study of mRNA-Based COVID-19 Vaccine Candidate

• T2 Biosystems Launches New COVID-19 Molecular Diagnostic Test

• FDA Issues Guidance to Facilitate Timely Development of Safe, Effective COVID-19 Vaccines

• Roche Secures FDA Emergency Use Authorization for Elecsys IL-6 Test to Identify Severe Inflammatory Response in COVID-19 Patients

• AI Platform Identifies 68 Genes Associated with High Risk of Severe COVID-19

• Revolutionary COVID-19 Patient Isolation Transport System Minimizes Infection Risk to Medical Personnel

• Nucleic-Acid Based COVID-19 Vaccine Candidate Generates Immune Responses in 94% of Phase 1 Trial Participants

• Interactive Data Visualization Tool Connects Scientists Worldwide with Vital COVID-19 Research Data